ASH 2022 Conference Coverage
ASH 2022 Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in R/R FL: Analysis of Safety, Efficacy, and MRD
By
ASH 2022 Conference Coverage
FEATURING
Christopher J. Melani
By
ASH 2022 Conference Coverage
FEATURING
Christopher J. Melani
Login to view comments.
Click here to Login